Psyence Biomedical PBM Ratios (2022-2026)

NASDAQ PBM
$4.52 +0.28 (+6.60%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Psyence Biomedical Quarterly Ratios

Periods 8 quarters
Latest Mar 2026

Psyence Biomedical ratios data for the quarter ended Mar 2026. These financial ratios cover 8 quarters of results from Dec 2022 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Profitability
EBT Margin -2,148.06%
EBIT Margin -2,144.14%
EBITDA Margin -2,142.24%
Net Margin -1,075.12%
Efficiency
Assets AverageAssets Avg. 130.38M130.26M7.14M6.91M1.69M4.78M10.06M15.19M
Equity AverageEquity Avg. -6.10M-5.98M-6.11M2.73M9.29M14.41M
Invested CapitalInvested Cap. 0.63M
Leverage & Solvency
Interest Coverage RatioInterest Cover -5.31-310.20-545.67
Debt Ratio 0.13
Times Interest Earned -5.31-310.20-545.67
Valuation
Price to BookP/B 0.860.330.08
Enterprise Value 24,945.24M34,590.77M465.38M38.95M-0.34M-3.29M-6.09M
Market Capitalization 24,946.57M34,591.38M466.11M40.89M5.79M3.86M1.36M
Return Ratios
Return on Sales [ROS]ROS -2,144.14%

Psyence Biomedical Ratios API

Pull Psyence Biomedical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PBM&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY